|
市場調査レポート
商品コード
1746637
日本のホルモン補充療法市場レポート：製品別、投与経路別、疾患タイプ別、地域別、2025年～2033年Japan Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
| 日本のホルモン補充療法市場レポート：製品別、投与経路別、疾患タイプ別、地域別、2025年～2033年 |
|
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 120 Pages
納期: 5～7営業日
|
- 全表示
- 概要
- 目次
日本のホルモン補充療法市場規模は2024年に5億6,780万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに10億1,120万米ドルに達し、2025年から2033年にかけて6.60%の成長率（CAGR）を示すと予測しています。この業界は、ホルモン障害の発生率の増加、注目すべき技術の進歩、送達技術の継続的な革新、支援的な政府プログラムおよび償還政策など、いくつかの主要な促進要因によって成長を経験しています。
本レポートで扱う主な質問
- 日本のホルモン補充療法市場はこれまでどのように推移し、今後どのように推移するのか？
- COVID-19が日本のホルモン補充療法市場に与えた影響は？
- 日本のホルモン補充療法市場の製品別区分は？
- 日本のホルモン補充療法市場の投与経路別区分は？
- 日本のホルモン補充療法市場の疾病タイプ別区分は？
- 日本のホルモン補充療法市場のバリューチェーンにおける様々な段階とは？
- 日本のホルモン補充療法における主要な促進要因と課題は何か？
- 日本のホルモン補充療法市場の構造と主要企業は？
- 日本のホルモン補充療法市場における競合の程度は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 市場推定
- 調査手法
第3章 エグゼクティブサマリー
第4章 日本のホルモン補充療法市場-イントロダクション
- 概要
- 市場力学
- 業界動向
- 競合情報
第5章 日本のホルモン補充療法市場情勢
- 過去および現在の市場動向（2019～2024年）
- 市場予測（2025～2033年）
第6章 日本のホルモン補充療法市場- 製品別内訳
- エストロゲン補充療法
- 人間の成長ホルモン補充療法
- 甲状腺補充療法
- テストステロン補充療法
- その他
第7章 日本のホルモン補充療法市場- 投与経路別の内訳
- 経口
- 非経口
- 経皮
第8章 日本のホルモン補充療法市場- 疾患タイプ別の内訳
- 閉経
- 甲状腺機能低下症
- 男性性腺機能低下症
- 成長ホルモン欠乏症
- その他
第9章 日本のホルモン補充療法市場-競合情勢
- 概要
- 市場構造
- 市場企業のポジショニング
- 主要成功戦略
- 競合ダッシュボード
- 企業評価象限
第10章 主要企業のプロファイル
第11章 日本のホルモン補充療法市場- 業界分析
- 促進要因・抑制要因・機会
- ポーターのファイブフォース分析
- バリューチェーン分析
第12章 付録
Japan hormone replacement therapy market size reached USD 567.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,011.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.60% during 2025-2033. The industry is experiencing growth due to several key drivers, including the increasing incidence of hormonal disorders, notable technological advancements, continuous innovations in delivery techniques, and supportive government programs and reimbursement policies.
Hormone replacement therapy (HRT) is a medical approach employed to address hormonal imbalances in individuals. This treatment involves the administration of external hormones to supplement or substitute the natural hormones produced by the body. Typically, healthcare providers, such as endocrinologists or gynecologists, prescribe HRT after a comprehensive assessment of the patient's medical history and symptoms. HRT's objective is to alleviate symptoms related to hormonal deficiencies or variations by consistently delivering controlled hormone doses. The treatment undergoes careful monitoring to ensure that hormone levels remain within the desired range, promoting overall well-being and potentially mitigating the negative effects of hormonal imbalances.
Japan Hormone Replacement Therapy Market Trends:
The Japan hormone replacement therapy market is experiencing substantial growth, driven by a combination of factors that align with global healthcare trends. A key driver is the increasing prevalence of hormonal imbalances and related disorders, which are becoming more prevalent in the population due to factors like sedentary lifestyles, stress, and the natural process of aging. These factors have created a growing need for therapeutic interventions such as hormone replacement therapy. Furthermore, the market benefits from the rising awareness and acceptance of HRT as an effective treatment option among both patients and healthcare professionals. This increasing recognition has contributed to the expansion of the market in Japan. The aging demographic in Japan is another significant driver, as hormonal imbalances become more common with age. This demographic shift has led to a higher demand for HRT among the elderly population. Moreover, ongoing technological advancements in hormone delivery methods, such as transdermal patches and implantable devices, are making HRT more convenient and targeted in its administration. This enhances patient compliance and improves treatment outcomes, further fueling market growth. Additionally, supportive government initiatives and favorable reimbursement policies aimed at ensuring affordable access to HRT for patients are creating favorable conditions for market expansion. These collective factors will underscore the growing importance and potential of the Japan hormone replacement therapy market in addressing hormonal imbalances and related health concerns over the forecasted period.
Japan Hormone Replacement Therapy Market Segmentation:
Product Insights:
- Estrogen Replacement Therapy
- Human Growth Hormone Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
- Others
Route of Administration Insights:
- Oral
- Parenteral
- Transdermal
Type of Disease Insights:
- Menopause
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan hormone replacement therapy market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan hormone replacement therapy market?
- What is the breakup of the Japan hormone replacement therapy market on the basis of product?
- What is the breakup of the Japan hormone replacement therapy market on the basis of route of administration?
- What is the breakup of the Japan hormone replacement therapy market on the basis of type of disease?
- What are the various stages in the value chain of the Japan hormone replacement therapy market?
- What are the key driving factors and challenges in the Japan hormone replacement therapy?
- What is the structure of the Japan hormone replacement therapy market and who are the key players?
- What is the degree of competition in the Japan hormone replacement therapy market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Hormone Replacement Therapy Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Hormone Replacement Therapy Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Hormone Replacement Therapy Market - Breakup by Product
- 6.1 Estrogen Replacement Therapy
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Human Growth Hormone Replacement Therapy
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Thyroid Replacement Therapy
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Testosterone Replacement Therapy
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
- 6.5 Others
- 6.5.1 Historical and Current Market Trends (2019-2024)
- 6.5.2 Market Forecast (2025-2033)
7 Japan Hormone Replacement Therapy Market - Breakup by Route of Administration
- 7.1 Oral
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Parenteral
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Transdermal
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
8 Japan Hormone Replacement Therapy Market - Breakup by Type of Disease
- 8.1 Menopause
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Hypothyroidism
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Male Hypogonadism
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
- 8.4 Growth Hormone Deficiency
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
- 8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)
9 Japan Hormone Replacement Therapy Market - Competitive Landscape
- 9.1 Overview
- 9.2 Market Structure
- 9.3 Market Player Positioning
- 9.4 Top Winning Strategies
- 9.5 Competitive Dashboard
- 9.6 Company Evaluation Quadrant
10 Profiles of Key Players
- 10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
- 10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
- 10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
- 10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
- 10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events
11 Japan Hormone Replacement Therapy Market - Industry Analysis
- 11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
- 11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
- 11.3 Value Chain Analysis
